Bio Solution바이오솔루션
086820 · KOSDAQ · ₩086820 · 바이오솔루션
₩5,460▼ ₩130 (2.33%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 65.7% | 63.1% | 63.3% | 65.2% | 58.7% | 64.5% |
| Operating margin | −19.3% | −28.6% | −39.3% | −40.4% | −52.4% | −13.3% |
| Net margin | 5.0% | 1.8% | −92.6% | −10.0% | −80.1% | −14.3% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +14.4% | +17.9% | +3.4% | +23.4% | −14.4% | — |
| Operating income growth | +22.5% | +14.4% | −0.7% | +4.9% | −236.4% | — |
| Net income growth | +217.9% | +102.3% | −855.0% | +84.6% | −380.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 2.4% | 0.9% | −32.5% | −2.9% | −18.2% | −3.7% |
| Return on assets | 0.7% | 0.4% | −14.9% | −1.4% | −8.7% | −1.8% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 60.4% | 114.0% | 115.8% | 119.0% | 109.5% | 109.7% |
| Net debt to equity | 17.8% | 53.0% | 38.3% | −8.6% | 18.8% | −66.6% |
| Current ratio | 83.7% | 56.7% | 62.9% | 94.1% | 172.6% | 178.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Bio Solution / 바이오솔루션 / 086820 / KRX:086820
Source: KRX statistical information